Milind Javle, MD
M.D. Anderson Cancer Center · Roswell Park Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Milind Javle, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:10 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05948475 · Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in CholangiocarcinomaTransThera Sciences (Nanjing), Inc. · active not recruiting · Cholangiocarcinoma · principal investigator
- Ph2NCT04919642 · Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in CholangiocarcinomaTransThera Sciences (Nanjing), Inc. · completed · Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation · principal investigator
- Ph1NCT00968604 · C-VISA BikDD: Liposome in Advanced Pancreatic CancerM.D. Anderson Cancer Center · withdrawn · Pancreatic Cancer · study chair
- Ph1/Ph2NCT00769483 · MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerM.D. Anderson Cancer Center · completed · Pancreatic Cancer, Pancreatic Adenocarcinoma · principal investigator
- Ph2NCT00640978 · Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerM.D. Anderson Cancer Center · terminated · Pancreatic Cancer · principal investigator
- Ph1/Ph2NCT00093652 · Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerRoswell Park Cancer Institute · terminated · Esophageal Cancer · principal investigator
- Ph2NCT00084942 · Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderRoswell Park Cancer Institute · completed · Extrahepatic Bile Duct Cancer, Gallbladder Cancer · principal investigator
- N/ANCT00040820 · Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerRoswell Park Cancer Institute · completed · Colorectal Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Phase I Study of the BikDD Nanoparticle for Advanced Cancer of the PancreasR21CA135604 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Milind Javle · fiscal years 2009 to 2011Named on NCT00968604
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.